New combo therapy shows promise for Hard-to-Treat cancers
NCT ID NCT05001347
First seen Jan 09, 2026 · Last updated May 12, 2026 · Updated 20 times
Summary
This study tested a new drug (TJ004309) combined with an approved immunotherapy (atezolizumab) in 25 people with advanced ovarian, head and neck, lung, gastrointestinal, or triple-negative breast cancers. The goal was to see if the combination could shrink tumors. Participants had cancers that stopped responding to standard treatments. The study is complete, and results help guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arizona Oncology Associates
Tucson, Arizona, 85711, United States
-
Duke Cancer Center
Durham, North Carolina, 27710, United States
-
Illinois Cancer Specialists
Arlington Heights, Illinois, 60005, United States
-
Innovative Clinical Research Institute
Whittier, California, 90603, United States
-
Laura and Isaac Perlmutter Cancer Center at NYU Langone
New York, New York, 10016, United States
-
Maryland Oncology Hematology
Rockville, Maryland, 20850, United States
-
Medical Oncology Hematology Consultants, PA
Newark, Delaware, 19713, United States
-
Northwest Cancer Specialists
Vancouver, Washington, 98684, United States
-
Texas Oncology - Arlington North
Arlington, Texas, 76012, United States
-
Texas Oncology - Austin Central
Austin, Texas, 78731, United States
-
Texas Oncology - Forth Worth Cancer Center
Fort Worth, Texas, 76104, United States
-
Texas Oncology - The Woodlands, Gynecologic Oncology
The Woodlands, Texas, 77380, United States
-
Tri County Hematology and Oncology Associates
Massillon, Ohio, 44646, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
-
Women's Cancer Care
Covington, Louisiana, 70433, United States
Conditions
Explore the condition pages connected to this study.